AMENDMENT TO PURCHASE AGREEMENTPurchase Agreement • April 14th, 2004 • Coram Healthcare Corp • Services-home health care services
EXHIBIT 10.117 SPECIALIZED CLINICAL SERVICES, INC. SPECIALIZED CLINICIAN(R) SYSTEM SOURCE CODE LICENSE AND SUPPORT AGREEMENT This Agreement is entered into as of the date set forth below between SPECIALIZED CLINICAL SERVICES, INC., a California...Software License Agreement • April 14th, 2004 • Coram Healthcare Corp • Services-home health care services • Delaware
EXHIBIT 10.115 (SSG CAPITAL ADVISORS, L.P. LETTERHEAD) December 10, 2003 Judge Arlin M. Adams Chapter 11 Trustee of Coram Healthcare Corporation And Coram, Inc. Schnader Harrison Segal & Lewis, LLP 1600 Market Street, Suite 3600 Philadelphia, PA...Engagement Agreement • April 14th, 2004 • Coram Healthcare Corp • Services-home health care services
March 2, 2004Advisory Services Agreement • April 14th, 2004 • Coram Healthcare Corp • Services-home health care services
1 Coram Amendment Revised 1.16.04Prime Vendor Agreement • April 14th, 2004 • Coram Healthcare Corp • Services-home health care services
RECITALS:Purchase Agreement • April 14th, 2004 • Coram Healthcare Corp • Services-home health care services
RECITALS:Purchase Agreement • April 14th, 2004 • Coram Healthcare Corp • Services-home health care services
CORAM HEALTHCARE 1675 Broadway Suite 900 Denver, Colorado 80202 303.292.4973 / 800 CORAM WC 303.298.0043 FAX www.coramhc.com April 2, 2004 Rosalee Satterthwaite National Accounts Manager Baxter Healthcare Corporation 1627 Lake Cook Road Deerfield,...Mutual Waiver of Damages • April 14th, 2004 • Coram Healthcare Corp • Services-home health care services
The purpose of this letter is to confirm the agreement of Baxter Healthcare Corporation ("Baxter") and Coram, Inc. ("Coram") that, as of the date written below, each of Baxter and Coram expressly waive any claim of antecedent breach for claims for monetary damages, liquidated or otherwise, arising out of the other party's breach of the Product Volume Commitment Agreement dated December 19, 2001 by and between Baxter and Coram, as amended by the First Amendment to Hemophilia Product Volume Commitment Agreement dated December 13, 2002 and the Second Amendment to Hemophilia Product Volume Commitment Agreement dated September 24, 2003 and the Extension of Pricing Terms dated March 31, 2004.
